| P2093 | author name string | Danielle Duffy | |
| | Geoffrey Mills | |
| | David Whellan | |
| | Erik Kelly | |
| | Amanda Trang | |
| P2860 | cites work | Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association | Q22306356 |
| | Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials | Q24645391 |
| | Risk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric-coated formulations | Q24798492 |
| | Get with the guidelines for cardiovascular secondary prevention: pilot results | Q28166953 |
| | Aspirin use post-acute coronary syndromes: intolerance, bleeding and discontinuation | Q28168267 |
| | Diagnosis, treatment, and long-term management of Kawasaki disease | Q28171298 |
| | Non-adherence to aspirin or oral anticoagulants in secondary prevention after ischaemic stroke | Q28174704 |
| | Helicobacter pylori infection as a risk factor for gastrointestinal symptoms in patients using aspirin to prevent ischaemic heart disease | Q28185607 |
| | Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke | Q28186463 |
| | Adherence to medications by patients after acute coronary syndromes | Q28192360 |
| | Improving quality of care for acute myocardial infarction: The Guidelines Applied in Practice (GAP) Initiative | Q28192496 |
| | Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin | Q28192693 |
| | ??? | Q28249469 |
| | The impact of medication adherence on coronary artery disease costs and outcomes: a systematic review | Q38090858 |
| | Aspirin: its risks, benefits, and optimal use in preventing cardiovascular events | Q38103496 |
| | The Impact of Upper Gastrointestinal Symptoms on Nonadherence to, and Discontinuation of, Low-Dose Acetylsalicylic Acid in Patients with Cardiovascular Risk | Q38371646 |
| | Adherence to aspirin in the prevention of myocardial infarction. The Physicians' Health Study | Q40650868 |
| | Adherence to a prophylactic medication regimen in patients with symptomatic versus asymptomatic ischemic heart disease | Q40860434 |
| | Prophylactic aspirin and risk of peptic ulcer bleeding | Q41848139 |
| | Outpatient cardiology practices with advanced practice nurses and physician assistants provide similar delivery of recommended therapies (findings from IMPROVE HF). | Q43032136 |
| | Effect of motivational mobile phone short message service on aspirin adherence after coronary stenting for acute coronary syndrome | Q43486231 |
| | Enhancing medical adherence | Q43689473 |
| | 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines | Q44265041 |
| | Low-dose acetylsalicylic acid and gastrointestinal ulcers or bleeding--a cohort study of the effects of proton pump inhibitor use patterns | Q44665525 |
| | Impact of gastrointestinal problems on adherence to low-dose acetylsalicylic Acid: a quantitative study in patients with cardiovascular risk | Q44974747 |
| | 2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary. A report of the American College of Cardiology Foundation/American | Q45352452 |
| | Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study | Q46105962 |
| | Efficacy of esomeprazole (20 mg once daily) for reducing the risk of gastroduodenal ulcers associated with continuous use of low-dose aspirin | Q46476290 |
| | Analysis of the risk factors and their combinations in acute gastroduodenal ulcer bleeding: a case-control study | Q46906556 |
| | Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients | Q47432715 |
| | A survey on adherence to secondary ischemic stroke prevention | Q48658232 |
| | Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product. | Q50989183 |
| | A pilot study evaluating multiple risk factor interventions by community pharmacists to prevent cardiovascular disease: the PAART CVD pilot project. | Q51361620 |
| | Compliance with secondary prevention of ischemic stroke: a prospective evaluation. | Q52962840 |
| | Adherence to secondary prevention medications and four-year outcomes in outpatients with atherosclerosis. | Q53107873 |
| | AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. | Q55055148 |
| | Guideline-Based Standardized Care Is Associated With Substantially Lower Mortality in Medicare Patients With Acute Myocardial Infarction | Q57611676 |
| | Compliance with aspirin or placebo in the hypertension optimal treatment (HOT) study | Q57987943 |
| | Risk of upper gastrointestinal bleeding in patients taking low-dose aspirin for the prevention of cardiovascular diseases | Q28193996 |
| | Long-term adherence with cardiovascular drug regimens | Q28194045 |
| | Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease | Q28194421 |
| | Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence | Q28195518 |
| | Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study | Q28198544 |
| | Impact of medication therapy discontinuation on mortality after myocardial infarction | Q28200545 |
| | A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease | Q28200844 |
| | Persistent depressive symptoms lower aspirin adherence after acute coronary syndromes | Q28201292 |
| | Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations | Q28217824 |
| | Incidence and predictors of upper gastrointestinal bleeding in patients receiving low-dose aspirin for secondary prevention of cardiovascular events in patients with coronary artery disease | Q28218326 |
| | Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment | Q28218361 |
| | Long-term continuation on cardiovascular drug treatment in patients with coronary heart disease | Q28220890 |
| | Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the american heart association/american stroke association | Q28296349 |
| | Adherence to Medication | Q28314923 |
| | A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee | Q29620666 |
| | Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association | Q30501645 |
| | A systematic review of the associations between dose regimens and medication compliance | Q30719289 |
| | Guidelines for prevention of NSAID-related ulcer complications | Q33412100 |
| | Improving the physician-patient cardiovascular risk dialogue to improve statin adherence | Q33476545 |
| | Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice | Q33707148 |
| | Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association | Q34153132 |
| | 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/Non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiol | Q34288425 |
| | Mechanism of the irreversible inhibition of human cyclooxygenase-1 by aspirin as predicted by QM/MM calculations | Q34326436 |
| | Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial | Q34655833 |
| | Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement | Q34964056 |
| | State of the science: promoting self-care in persons with heart failure: a scientific statement from the American Heart Association | Q35000500 |
| | Risk of Upper Gastrointestinal Bleeding in a Cohort of New Users of Low-Dose ASA for Secondary Prevention of Cardiovascular Outcomes. | Q35117393 |
| | Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines | Q35752573 |
| | Antithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. | Q35752576 |
| | Primary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines | Q35752598 |
| | Beyond medication prescription as performance measures: optimal secondary prevention medication dosing after acute myocardial infarction | Q37285018 |
| | Low-dose aspirin therapy for cardiovascular prevention: quantification and consequences of poor compliance or discontinuation | Q37718219 |
| | Risk factors for gastrointestinal bleeding associated with low-dose aspirin | Q38006211 |
| | The worldwide environment of cardiovascular disease: prevalence, diagnosis, therapy, and policy issues: a report from the American College of Cardiology | Q38069009 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | aspirin | Q18216 |
| P304 | page(s) | 18-28 | |
| P577 | publication date | 2014-01-01 | |
| P1433 | published in | Postgraduate Medicine | Q7234297 |
| P1476 | title | Aspirin for cardioprotection and strategies to improve patient adherence | |
| P478 | volume | 126 | |